Cette entreprise dispose de données financières très limitées. Seules les informations de base sont disponibles.

NOVACARE INVEST : revenue, balance sheet and financial ratios

NOVACARE INVEST is a French company founded 4 years ago, specialized in the sector Gestion de fonds. Based in SOUAL (81580), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - NOVACARE INVEST (SIREN 901649541)
Indicator 2023
Revenue N/C
Net income 0 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2023, NOVACARE INVEST records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Positioning of NOVACARE INVEST in its sector

Comparison with sector Gestion de fonds

Similar companies (Gestion de fonds)

Compare NOVACARE INVEST with other companies in the same sector:

Frequently asked questions about NOVACARE INVEST

What is the revenue of NOVACARE INVEST ?

The revenue of NOVACARE INVEST is not publicly disclosed (confidential accounts filed with INPI).

Is NOVACARE INVEST profitable?

Profitability information is not publicly available.

Where is the headquarters of NOVACARE INVEST ?

The headquarters of NOVACARE INVEST is located in SOUAL (81580), in the department Tarn.

Where to find the tax return of NOVACARE INVEST ?

The tax return of NOVACARE INVEST is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does NOVACARE INVEST operate?

NOVACARE INVEST operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.